Suchergebnisse - "Grande, Enrique"

PubPharm (270)

1

Global real-world experiences with pembrolizumab in advanced urothelial carcinoma after platinum-based chemotherapy : the ARON-2 study

enthalten in: Cancer immunology, immunotherapy : CII | 2024

von Massari, F. | Santoni, M. | Takeshita, H. | +94

2

Global real-world experiences with pembrolizumab in advanced urothelial carcinoma after platinum-based chemotherapy: the ARON-2 study

enthalten in: Cancer immunology immunotherapy | 2024

von Massari, F. | Santoni, M. | Takeshita, H. | +94

3

Corrigendum to "Sex differences on multikinase inhibitors toxicity in patients with advanced gastroenteropancreatic neuroendocrine tumours" [Eur J Cancer 188 (2023) 39-48

enthalten in: European journal of cancer (Oxford, England : 1990) | 2024

von Hernando, J. | Roca-Herrera, M. | García-Álvarez, A. | +16

ErratumFor: Eur J Cancer. 2023 Jul;188:39-48. - PMID 37196483

4

Systemic Immune-Inflammation Index in Patients Treated With First-Line Immune Combinations for Metastatic Renal Cell Carcinoma : Insights From the ARON-1 Study

enthalten in: Clinical genitourinary cancer | 2024

von Monteiro, F. | Fiala, O. | Massari, F. | +17

5

Papillary Renal Cell Carcinoma : Outcomes for Patients Receiving First-line Immune-based Combinations or Tyrosine Kinase Inhibitors from the ARON-1 Study

enthalten in: European urology oncology | 2024

von Massari, F. | Mollica, V. | Fiala, O. | +21

6

Health-related Quality of Life in Patients with Previously Treated Advanced Urothelial Carcinoma from EV-301 : A Phase 3 Trial of Enfortumab Vedotin Versus Chemotherapy

enthalten in: European urology | 2024

von Rosenberg, J. | Mamtani, R. | Sonpavde, G. | +28

7

Bladder Cancer, Loss of Y Chromosome, and New Opportunities for Immunotherapy

enthalten in: Advances in therapy | 2024

von Mankan, A. | Mankan, N. | de Las Heras, B. | +5

8

Immunomodulatory effects and improved outcomes with cisplatin- versus carboplatin-based chemotherapy plus atezolizumab in urothelial cancer

enthalten in: Cell reports. Medicine | 2024

von Galsky, M. | Guan, X. | Rishipathak, D. | +30

9

Repotrectinib in ROS1 Fusion-Positive Non-Small-Cell Lung Cancer

enthalten in: The New England journal of medicine | 2024

von Drilon, A. | Camidge, D. | Lin, J. | +131

10

Bladder Cancer, Loss of Y Chromosome, and New Opportunities for Immunotherapy

enthalten in: Advances in therapy | 2024

von Mankan, A. | Mankan, N. | de las Heras, B. | +5

1
2
3
4
5
6
7
8
9
10
11
Nächster »
[27]